BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25212749)

  • 1. Ondansetron and sertraline may interact with 5-HTTLPR and DRD4 polymorphisms to reduce drinking in non-treatment seeking alcohol-dependent women: exploratory findings.
    Kenna GA; Zywiak WH; Swift RM; McGeary JE; Clifford JS; Shoaff JR; Fricchione S; Brickley M; Beaucage K; Haass-Koffler CL; Leggio L
    Alcohol; 2014 Sep; 48(6):515-22. PubMed ID: 25212749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ondansetron reduces naturalistic drinking in nontreatment-seeking alcohol-dependent individuals with the LL 5'-HTTLPR genotype: a laboratory study.
    Kenna GA; Zywiak WH; Swift RM; McGeary JE; Clifford JS; Shoaff JR; Vuittonet C; Fricchione S; Brickley M; Beaucage K; Haass-Koffler CL; Leggio L
    Alcohol Clin Exp Res; 2014 Jun; 38(6):1567-74. PubMed ID: 24773166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A within-group design of nontreatment seeking 5-HTTLPR genotyped alcohol-dependent subjects receiving ondansetron and sertraline.
    Kenna GA; Zywiak WH; McGeary JE; Leggio L; McGeary C; Wang S; Grenga A; Swift RM
    Alcohol Clin Exp Res; 2009 Feb; 33(2):315-23. PubMed ID: 19032576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking.
    Johnson BA; Ait-Daoud N; Seneviratne C; Roache JD; Javors MA; Wang XQ; Liu L; Penberthy JK; DiClemente CC; Li MD
    Am J Psychiatry; 2011 Mar; 168(3):265-75. PubMed ID: 21247998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HTTLPR genotype and daily negative mood moderate the effects of sertraline on drinking intensity.
    Kranzler HR; Armeli S; Tennen H; Covault J
    Addict Biol; 2013 Nov; 18(6):1024-31. PubMed ID: 23145795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the DRD4 exon III and 5-HTTLPR VNTR polymorphisms with substance abuse in Jordanian Arab population.
    Al-Eitan LN; Alshudaifat KM; Anani JY
    Gene; 2020 Apr; 733():144267. PubMed ID: 31809838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between serotonin transporter promoter and dopamine receptor D4 polymorphisms on decision making.
    Ha RY; Namkoong K; Kang JI; Kim YT; Kim SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1217-22. PubMed ID: 19615421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of genotype combinations that can predict the outcome of the treatment of alcohol dependence using the 5-HT(3) antagonist ondansetron.
    Johnson BA; Seneviratne C; Wang XQ; Ait-Daoud N; Li MD
    Am J Psychiatry; 2013 Sep; 170(9):1020-31. PubMed ID: 23897038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin transporter genomic biomarker for quantitative assessment of ondansetron treatment response in alcoholics.
    Seneviratne C; Johnson BA
    Front Psychiatry; 2012; 3():23. PubMed ID: 22470354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The conditioning of intervention effects on early adolescent alcohol use by maternal involvement and dopamine receptor D4 (DRD4) and serotonin transporter linked polymorphic region (5-HTTLPR) genetic variants.
    Cleveland HH; Schlomer GL; Vandenbergh DJ; Feinberg M; Greenberg M; Spoth R; Redmond C; Shriver MD; Zaidi AA; Hair KL
    Dev Psychopathol; 2015 Feb; 27(1):51-67. PubMed ID: 25640830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-treatment outcomes in a double-blind, randomized trial of sertraline for alcohol dependence.
    Kranzler HR; Armeli S; Tennen H
    Alcohol Clin Exp Res; 2012 Apr; 36(4):739-44. PubMed ID: 21981418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between the dopamine D4 receptor and the serotonin transporter promoter polymorphisms in alcohol and tobacco use among 15-year-olds.
    Skowronek MH; Laucht M; Hohm E; Becker K; Schmidt MH
    Neurogenetics; 2006 Nov; 7(4):239-46. PubMed ID: 16819620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetically driven treatments for alcoholism: are we there yet?
    Arias AJ; Sewell RA
    CNS Drugs; 2012 Jun; 26(6):461-76. PubMed ID: 22587755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, randomized trial of sertraline for alcohol dependence: moderation by age of onset [corrected] and 5-hydroxytryptamine transporter-linked promoter region genotype.
    Kranzler HR; Armeli S; Tennen H; Covault J; Feinn R; Arias AJ; Pettinati H; Oncken C
    J Clin Psychopharmacol; 2011 Feb; 31(1):22-30. PubMed ID: 21192139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between tridimensional personality questionnaire (TPQ) traits and three functional polymorphisms: dopamine receptor D4 (DRD4), serotonin transporter promoter region (5-HTTLPR) and catechol O-methyltransferase (COMT).
    Benjamin J; Osher Y; Kotler M; Gritsenko I; Nemanov L; Belmaker RH; Ebstein RP
    Mol Psychiatry; 2000 Jan; 5(1):96-100. PubMed ID: 10673775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human laboratory pilot study with baclofen in alcoholic individuals.
    Leggio L; Zywiak WH; McGeary JE; Edwards S; Fricchione SR; Shoaff JR; Addolorato G; Swift RM; Kenna GA
    Pharmacol Biochem Behav; 2013 Feb; 103(4):784-91. PubMed ID: 23262301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled, pharmacogenetic study of ondansetron for treating alcohol use disorder.
    Seneviratne C; Gorelick DA; Lynch KG; Brown C; Romer D; Pond T; Kampman K; Kranzler HR
    Alcohol Clin Exp Res; 2022 Oct; 46(10):1900-1912. PubMed ID: 36055978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in the Serotonin Transporter Gene and Alcoholism: Risk and Response to Pharmacotherapy.
    Thompson MD; Kenna GA
    Alcohol Alcohol; 2016 Mar; 51(2):164-71. PubMed ID: 26311211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of DRD4 exon III and 5-HTTLPR VNTR genetic polymorphisms with psychiatric symptoms in hemodialysis patients.
    Alshogran OY; Al-Eitan LN; Altawalbeh SM; Aman HA
    PLoS One; 2021; 16(3):e0249284. PubMed ID: 33784353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association of 5-HTTLPR, DRD4 gene polymorphisms with the accident tendentiousness of drivers].
    Wang XM; Yang L; Zhang HY; Liu Y; Tang ZH; Wang J; Zheng YY; Huang KY
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2012 Jul; 30(7):497-500. PubMed ID: 22931814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.